A detailed history of Edmond De Rothschild Holding S.A. transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 19,170 shares of NVCT stock, worth $100,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,170
Previous 19,170 -0.0%
Holding current value
$100,067
Previous $121,000 0.83%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$7.85 - $11.78 $150,484 - $225,822
19,170 New
19,170 $159,000
Q2 2023

Aug 09, 2023

SELL
$12.62 - $18.4 $22,085 - $32,199
-1,750 Reduced 7.12%
22,820 $364,000
Q1 2023

May 11, 2023

BUY
$7.32 - $14.37 $179,852 - $353,070
24,570 New
24,570 $322,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $76.4M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.